stocks logo

PMN Valuation

ProMIS Neurosciences Inc
$
0.457
+0.002(0.440%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

PMN Relative Valuation

PMN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PMN is overvalued; if below, it's undervalued.
Intellectia AI SwingMax

Historical Valuation

ProMIS Neurosciences Inc (PMN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.06. The fair price of ProMIS Neurosciences Inc (PMN) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:0.45
Fair
-0.50
PE
1Y
3Y
5Y
Trailing
Forward
-0.77
EV/EBITDA
ProMIS Neurosciences Inc. (PMN) has a current EV/EBITDA of -0.77. The 5-year average EV/EBITDA is -1.10. The thresholds are as follows: Strongly Undervalued below -3.19, Undervalued between -3.19 and -2.15, Fairly Valued between -0.06 and -2.15, Overvalued between -0.06 and 0.99, and Strongly Overvalued above 0.99. The current Forward EV/EBITDA of -0.77 falls within the Historic Trend Line -Fairly Valued range.
-0.43
EV/EBIT
ProMIS Neurosciences Inc. (PMN) has a current EV/EBIT of -0.43. The 5-year average EV/EBIT is -2.02. The thresholds are as follows: Strongly Undervalued below -4.48, Undervalued between -4.48 and -3.25, Fairly Valued between -0.79 and -3.25, Overvalued between -0.79 and 0.43, and Strongly Overvalued above 0.43. The current Forward EV/EBIT of -0.43 falls within the Overvalued range.
0.00
PS
ProMIS Neurosciences Inc. (PMN) has a current PS of 0.00. The 5-year average PS is 2125.06. The thresholds are as follows: Strongly Undervalued below -6629.59, Undervalued between -6629.59 and -2252.27, Fairly Valued between 6502.39 and -2252.27, Overvalued between 6502.39 and 10879.72, and Strongly Overvalued above 10879.72. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-0.71
P/OCF
ProMIS Neurosciences Inc. (PMN) has a current P/OCF of -0.71. The 5-year average P/OCF is -2.24. The thresholds are as follows: Strongly Undervalued below -9.19, Undervalued between -9.19 and -5.72, Fairly Valued between 1.24 and -5.72, Overvalued between 1.24 and 4.72, and Strongly Overvalued above 4.72. The current Forward P/OCF of -0.71 falls within the Historic Trend Line -Fairly Valued range.
-1.10
P/FCF
ProMIS Neurosciences Inc. (PMN) has a current P/FCF of -1.10. The 5-year average P/FCF is -0.08. The thresholds are as follows: Strongly Undervalued below -0.66, Undervalued between -0.66 and -0.37, Fairly Valued between 0.21 and -0.37, Overvalued between 0.21 and 0.50, and Strongly Overvalued above 0.50. The current Forward P/FCF of -1.10 falls within the Strongly Undervalued range.
ProMIS Neurosciences Inc (PMN) has a current Price-to-Book (P/B) ratio of -38.88. Compared to its 3-year average P/B ratio of 38.46 , the current P/B ratio is approximately -201.10% higher. Relative to its 5-year average P/B ratio of 20.53, the current P/B ratio is about -289.37% higher. ProMIS Neurosciences Inc (PMN) has a Forward Free Cash Flow (FCF) yield of approximately -110.02%. Compared to its 3-year average FCF yield of -62.04%, the current FCF yield is approximately 77.35% lower. Relative to its 5-year average FCF yield of -43.72% , the current FCF yield is about 151.63% lower.
-38.88
P/B
Median3y
38.46
Median5y
20.53
-110.02
FCF Yield
Median3y
-62.04
Median5y
-43.72
Financial AI Agent

Competitors Valuation Multiple

The average P/S ratio for PMN's competitors is 10.29, providing a benchmark for relative valuation. ProMIS Neurosciences Inc Corp (PMN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
AI Stock Picker

Performance Decomposition

1Y
3Y
5Y
Market capitalization of PMN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PMN in the past 1 year is driven by Unknown.

FAQ

arrow icon

Is ProMIS Neurosciences Inc (PMN) currently overvalued or undervalued?

ProMIS Neurosciences Inc (PMN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.06. The fair price of ProMIS Neurosciences Inc (PMN) is between to according to relative valuation methord.
arrow icon

What is ProMIS Neurosciences Inc (PMN) fair value?

arrow icon

How does PMN's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for ProMIS Neurosciences Inc (PMN) as of Sep 19 2025?

arrow icon

What is the current FCF Yield for ProMIS Neurosciences Inc (PMN) as of Sep 19 2025?

arrow icon

What is the current Forward P/E ratio for ProMIS Neurosciences Inc (PMN) as of Sep 19 2025?

arrow icon

What is the current Forward P/S ratio for ProMIS Neurosciences Inc (PMN) as of Sep 19 2025?